Dual leucine zipper kinase is required for excitotoxicity-induced neuronal degeneration

Loss of dual leucine zipper kinase results in attenuated JNK/c-Jun stress response pathway activation and reduced neuronal degeneration after kainic acid–induced excitotoxic seizures.

[1]  R. Hanajima,et al.  Signaling , 2021, Encyclopedia of Evolutionary Psychological Science.

[2]  C. Pozniak,et al.  JNK-mediated phosphorylation of DLK suppresses its ubiquitination to promote neuronal apoptosis , 2013, The Journal of cell biology.

[3]  Zhiyu Jiang,et al.  DLK initiates a transcriptional program that couples apoptotic and regenerative responses to axonal injury , 2013, Proceedings of the National Academy of Sciences.

[4]  S. Oliet,et al.  Synaptic and Extrasynaptic NMDA Receptors Are Gated by Different Endogenous Coagonists , 2012, Cell.

[5]  J. Milbrandt,et al.  Dual Leucine Zipper Kinase Is Required for Retrograde Injury Signaling and Axonal Regeneration , 2012, Neuron.

[6]  D. J. Cook,et al.  Treatment of stroke with a PSD-95 inhibitor in the gyrencephalic primate brain , 2012, Nature.

[7]  M. Sheng,et al.  The postsynaptic organization of synapses. , 2011, Cold Spring Harbor perspectives in biology.

[8]  C. Pozniak,et al.  DLK induces developmental neuronal degeneration via selective regulation of proapoptotic JNK activity , 2011, The Journal of cell biology.

[9]  T. Blank,et al.  Hippocampal c-Jun-N-Terminal Kinases Serve as Negative Regulators of Associative Learning , 2010, The Journal of Neuroscience.

[10]  Catherine A. Collins,et al.  Protein turnover of the Wallenda/DLK kinase regulates a retrograde response to axonal injury , 2010, The Journal of cell biology.

[11]  H. Bading,et al.  Synaptic versus extrasynaptic NMDA receptor signalling: implications for neurodegenerative disorders , 2010, Nature Reviews Neuroscience.

[12]  M. Naud,et al.  A peptide inhibitor of c-Jun N-terminal kinase for the treatment of endotoxin-induced uveitis. , 2010, Investigative ophthalmology & visual science.

[13]  A. Lau,et al.  Glutamate receptors, neurotoxicity and neurodegeneration , 2010, Pflügers Archiv - European Journal of Physiology.

[14]  M. Bogoyevitch,et al.  c-Jun N-terminal kinase (JNK) signaling: recent advances and challenges. , 2010, Biochimica et biophysica acta.

[15]  S. Briggs,et al.  Sunday Driver Interacts with Two Distinct Classes of Axonal Organelles*♦ , 2009, The Journal of Biological Chemistry.

[16]  J. Milbrandt,et al.  A dual leucine kinase–dependent axon self-destruction program promotes Wallerian degeneration , 2009, Nature Neuroscience.

[17]  V. Bennett,et al.  An Ankyrin-Based Mechanism for Functional Organization of Dystrophin and Dystroglycan , 2008, Cell.

[18]  S. Sternson,et al.  A FLEX Switch Targets Channelrhodopsin-2 to Multiple Cell Types for Imaging and Long-Range Circuit Mapping , 2008, The Journal of Neuroscience.

[19]  R. Burke,et al.  Antiapoptotic and Trophic Effects of Dominant-Negative Forms of Dual Leucine Zipper Kinase in Dopamine Neurons of the Substantia Nigra In Vivo , 2008, The Journal of Neuroscience.

[20]  S. Pfaff,et al.  The Ubiquitin Ligase Phr1 Regulates Axon Outgrowth through Modulation of Microtubule Dynamics , 2007, Neuron.

[21]  Xiongwei Zhu,et al.  c‐Jun phosphorylation in Alzheimer disease , 2007, Journal of neuroscience research.

[22]  H. Kiyonari,et al.  The c-Jun N-Terminal Kinase Activator Dual Leucine Zipper Kinase Regulates Axon Growth and Neuronal Migration in the Developing Cerebral Cortex , 2006, The Journal of Neuroscience.

[23]  O. Steward,et al.  Comparison of seizure phenotype and neurodegeneration induced by systemic kainic acid in inbred, outbred, and hybrid mouse strains , 2006, The European journal of neuroscience.

[24]  T. Herdegen,et al.  JNK1 phosphorylation of SCG10 determines microtubule dynamics and axodendritic length , 2006, The Journal of cell biology.

[25]  S. Grant,et al.  Molecular characterization and comparison of the components and multiprotein complexes in the postsynaptic proteome , 2006, Journal of neurochemistry.

[26]  K. Muir.  Glutamate-based therapeutic approaches: clinical trials with NMDA antagonists. , 2006, Current opinion in pharmacology.

[27]  Hideko Yamamoto,et al.  Low concentrations of nitric oxide (NO) induced cell death in PC12 cells through activation of p38 mitogen-activated protein kinase (p38 MAPK) but not via extracellular signal-regulated kinases (ERK1/2) or c-Jun N-terminal protein kinase (JNK) , 2006, Neuroscience Letters.

[28]  T. Herdegen,et al.  Context-specific inhibition of JNKs: overcoming the dilemma of protection and damage. , 2005, Trends in pharmacological sciences.

[29]  J. Zhu,et al.  Rap2-JNK Removes Synaptic AMPA Receptors during Depotentiation , 2005, Neuron.

[30]  Yanqin Gao,et al.  Neuroprotection against Focal Ischemic Brain Injury by Inhibition of c-Jun N-Terminal Kinase and Attenuation of the Mitochondrial Apoptosis-Signaling Pathway , 2005, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[31]  W. Gan,et al.  Development of Long-Term Dendritic Spine Stability in Diverse Regions of Cerebral Cortex , 2005, Neuron.

[32]  M. Ono,et al.  Expression of MUK/DLK/ZPK, an activator of the JNK pathway, in the nervous systems of the developing mouse embryo. , 2005, Gene expression patterns : GEP.

[33]  F Edward Dudek,et al.  Chemoconvulsant Model of Chronic Spontaneous Seizures , 2005, Current protocols in neuroscience.

[34]  G. Shepherd,et al.  Transient and Persistent Dendritic Spines in the Neocortex In Vivo , 2005, Neuron.

[35]  Steven P Gygi,et al.  Semiquantitative Proteomic Analysis of Rat Forebrain Postsynaptic Density Fractions by Mass Spectrometry* , 2004, Journal of Biological Chemistry.

[36]  Pasko Rakic,et al.  JNK-mediated induction of cyclooxygenase 2 is required for neurodegeneration in a mouse model of Parkinson's disease. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[37]  Eckart D Gundelfinger,et al.  Proteomics Analysis of Rat Brain Postsynaptic Density , 2004, Journal of Biological Chemistry.

[38]  P. Rakic,et al.  A critical role of neural-specific JNK3 for ischemic apoptosis , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[39]  Takashi Yamauchi,et al.  Molecular constituents of the postsynaptic density fraction revealed by proteomic analysis using multidimensional liquid chromatography‐tandem mass spectrometry , 2003, Journal of neurochemistry.

[40]  A. Vercelli,et al.  A peptide inhibitor of c-Jun N-terminal kinase protects against excitotoxicity and cerebral ischemia , 2003, Nature Medicine.

[41]  Mark Ellisman,et al.  JNK1 is required for maintenance of neuronal microtubules and controls phosphorylation of microtubule-associated proteins. , 2003, Developmental cell.

[42]  Yitao Liu,et al.  Treatment of Ischemic Brain Damage by Perturbing NMDA Receptor- PSD-95 Protein Interactions , 2002, Science.

[43]  T. Herdegen,et al.  c-Jun N-Terminal Protein Kinase (JNK) 2/3 Is Specifically Activated by Stress, Mediating c-Jun Activation, in the Presence of Constitutive JNK1 Activity in Cerebellar Neurons , 2002, The Journal of Neuroscience.

[44]  Andrew P McMahon,et al.  Efficient recombination in diverse tissues by a tamoxifen-inducible form of Cre: a tool for temporally regulated gene activation/inactivation in the mouse. , 2002, Developmental biology.

[45]  K. Murai,et al.  Contactin Supports Synaptic Plasticity Associated with Hippocampal Long-Term Depression but Not Potentiation , 2002, Current Biology.

[46]  N. Nakatsuji,et al.  Efficient gene transfer into the embryonic mouse brain using in vivo electroporation. , 2001, Developmental biology.

[47]  M. Greenberg,et al.  β-Amyloid Induces Neuronal Apoptosis Via a Mechanism that Involves the c-Jun N-Terminal Kinase Pathway and the Induction of Fas Ligand , 2001, The Journal of Neuroscience.

[48]  D. Guastella,et al.  NMDA But Not Non-NMDA Excitotoxicity is Mediated by Poly(ADP-Ribose) Polymerase , 2000, The Journal of Neuroscience.

[49]  M. Kennedy,et al.  Identification of Proteins in the Postsynaptic Density Fraction by Mass Spectrometry , 2000, The Journal of Neuroscience.

[50]  M Dickens,et al.  Interaction of a Mitogen-Activated Protein Kinase Signaling Module with the Neuronal Protein JIP3 , 2000, Molecular and Cellular Biology.

[51]  D. Choi,et al.  Apoptosis and Necrosis in Cerebrovascular Disease , 1999, Annals of the New York Academy of Sciences.

[52]  E. Wagner,et al.  Amino-terminal phosphorylation of c-Jun regulates stress-induced apoptosis and cellular proliferation , 1999, Nature Genetics.

[53]  M. Miller,et al.  CEP-1347/KT-7515, an inhibitor of c-jun N-terminal kinase activation, attenuates the 1-methyl-4-phenyl tetrahydropyridine-mediated loss of nigrostriatal dopaminergic neurons In vivo. , 1999, The Journal of pharmacology and experimental therapeutics.

[54]  R. Morris,et al.  Enhanced long-term potentiation and impaired learning in mice with mutant postsynaptic density-95 protein , 1998, Nature.

[55]  R. Huganir,et al.  SynGAP: a Synaptic RasGAP that Associates with the PSD-95/SAP90 Protein Family , 1998, Neuron.

[56]  P. Rakic,et al.  Absence of excitotoxicity-induced apoptosis in the hippocampus of mice lacking the Jnk3 gene , 1997, Nature.

[57]  William Slikker,et al.  Fluoro-Jade: a novel fluorochrome for the sensitive and reliable histochemical localization of neuronal degeneration , 1997, Brain Research.

[58]  L. Holzman,et al.  Characterization of Dual Leucine Zipper-bearing Kinase, a Mixed Lineage Kinase Present in Synaptic Terminals Whose Phosphorylation State Is Regulated by Membrane Depolarization via Calcineurin* , 1996, The Journal of Biological Chemistry.

[59]  T. Dawson,et al.  Resistance to neurotoxicity in cortical cultures from neuronal nitric oxide synthase-deficient mice , 1996, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[60]  Y. Ben-Ari,et al.  Apoptosis and Necrosis after Reversible Focal Ischemia: An in Situ DNA Fragmentation Analysis , 1996, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[61]  S. Lipton,et al.  Glutamate-induced neuronal death: A succession of necrosis or apoptosis depending on mitochondrial function , 1995, Neuron.

[62]  S. Lipton,et al.  Apoptosis and necrosis: two distinct events induced, respectively, by mild and intense insults with N-methyl-D-aspartate or nitric oxide/superoxide in cortical cell cultures. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[63]  A. Contestabile,et al.  Protection from kainic acid neuropathological syndrome by NMDA receptor antagonists: Effect of MK-801 and CGP 39551 on neurotransmitter and glial markers , 1992, Neuropharmacology.

[64]  Andrew Sherwood.  Cervical cytology screening. , 1988, BMJ.

[65]  D. Choi,et al.  Glutamate neurotoxicity in cortical cell culture is calcium dependent , 1985, Neuroscience Letters.

[66]  Y. Ben-Ari,et al.  Limbic seizure and brain damage produced by kainic acid: Mechanisms and relevance to human temporal lobe epilepsy , 1985, Neuroscience.

[67]  B. Meldrum,et al.  Blockade of N-methyl-D-aspartate receptors may protect against ischemic damage in the brain. , 1984, Science.

[68]  C. Cotman,et al.  Postsynaptic density antigens: preparation and characterization of an antiserum against postsynaptic densities , 1981, The Journal of cell biology.

[69]  D. J. Cook,et al.  Treatment of Stroke , 2014 .

[70]  A. Planas,et al.  Both apoptosis and necrosis occur following intrastriatal administration of excitotoxins , 2004, Acta Neuropathologica.

[71]  A Critical , 2022 .